Modeling the Cost-Effectiveness of Prothrombin Complex Concentrate Compared With Fresh Frozen Plasma in Emergency Warfarin Reversal in the United Kingdom

Clinical Therapeutics

Volumn 32, Issue 14, 2010, Pages 2478-2493

  Guest, Julian F ^a,b   Watson, Henry G ^c   Limaye, Sameer ^d  

^a CATALYST Health Economics Consultants   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^d YORK TEACHING HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cost; Cost effectiveness; Fresh frozen plasma; Gastrointestinal hemorrhage; Hemorrhage; Intracranial hemorrhage; Prothrombin complex concentrate; Retroperitoneal hemorrhage; Utility; Warfarin

Indexed keywords

FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; COST EFFECTIVENESS ANALYSIS; DECISION TREE; DRUG INDICATION; EMERGENCY TREATMENT; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; QUALITY ADJUSTED LIFE YEAR; RETROPERITONEAL HEMORRHAGE; SENSITIVITY ANALYSIS; STROKE; TREATMENT OUTCOME; UNITED KINGDOM; VEIN THROMBOSIS;

AGED; ANTICOAGULANTS; BLOOD COAGULATION FACTORS; BLOOD COMPONENT TRANSFUSION; COST-BENEFIT ANALYSIS; DECISION TREES; EMERGENCY MEDICAL SERVICES; GREAT BRITAIN; HEMORRHAGE; HUMANS; MODELS, ECONOMIC; PLASMA; QUALITY-ADJUSTED LIFE YEARS; TREATMENT OUTCOME; WARFARIN;

EID: 79951836170     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2011.01.011     Document Type: Article

References (41)

1. Baglin T.P., Keeling D.M., Watson H.G. Guidelines on oral anticoagulation (warfarin): Third edition-2005 update. Br J Haematol 2006, 132:277-285. British Committee for Standards in Haematology.
2. Palareti G., Leali N., Coccheri S., et al. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996, 348:423-428. Italian Study on Complications of Oral Anticoagulant Therapy.
3. Go A.S., Hylek E.M., Chang Y., et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials translate into clinical practice?. JAMA 2003, 290:2685-2692.
4. Makris M., Watson H.G. The management of coumarin-induced over-anticoagulation annotation. Br J Haematol 2001, 114:271-280.
5. Schulman S., Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005, 3:692-694. Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
6. Andrade M.M., Pimenta M.B., Belezia Bde F., et al. Abdominal compartment syndrome due to warfarin-related retroperitoneal hematoma. Clinics (Sao Paulo) 2007, 62:781-784.
7. Rosand J., Eckman M.H., Knudsen K.A., et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004, 164:880-884.
8. Thomopoulos K.C., Mimidis K.P., Theocharis G.J., et al. Acute upper gastrointestinal bleeding in patients on long-term oral anticoagulation therapy: Endoscopic findings, clinical management and outcome. World J Gastroenterol 2005, 11:1365-1368.
9. Ivascu F.A., Janczyk R.J., Bair H.A., et al. Spontaneous retroperitoneal hemorrhage. Am J Surg 2005, 189:345-347.
10. Baglin T. Management of warfarin (coumarin) overdose. Blood Rev 1998, 12:91-98.
11. Flaherty M.L., Haverbusch M., Sekar P., et al. Location and outcome of anticoagulant-associated intracerebral hemorrhage. Neurocrit Care 2006, 5:197-201.
12. Zubkov A., Claassen D.O., Rabinstein A.A. Warfarin-associated intraventricular hemorrhage. Neurol Res 2007, 29:661-663.
13. Cavallini A., Fanucchi S., Persico A. Warfarin-associated intracerebral hemorrhage. Neurol Sci 2008, 29(Suppl 2):S266-S268.
14. Fric-Shamji E.C., Shamji M.F., Cole J., Benoit B.G. Modifiable risk factors for intracerebral hemorrhage: Study of anticoagulated patients. Can Fam Physician 2008, 54:1138-1139. 139.e1-4.
15. Neau J.P., Couderq C., Ingrand P., et al. Intracranial hemorrhage and oral anticoagulant treatment. Cerebrovasc Dis 2001, 11:195-200. VGP Study Group.
16. Berwaerts J., Robb O.J., Dykhuizen R.S., Webster J. Course, management and outcome of oral anticoagulant-related intracranial haemorrhages. Scott Med J 2000, 45:105-109.
17. Själander A., Engström G., Berntorp E., Svensson P. Risk of haemorrhagic stroke in patients with oral anticoagulation compared with the general population. J Intern Med 2003, 24:434-438.
18. Gage B.F., Waterman A.D., Shannon W., et al. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001, 285:2864-2870.
19. Sjöblom L., Hårdemark H.G., Lindgren A., et al. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: A Swedish multicenter study. Stroke 2001, 32:2567-2574.
20. Yasaka M., Sakata T., Minematsu K., Naritomi H. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Thromb Res 2002, 108:25-30.
21. Cartmill M., Dolan G., Byrne J.L., Byrne P.O. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br J Neurosurg 2000, 14:458-461.
22. Boulis N.M., Bobek M.P., Schmaier A., Hoff J.T. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 1999, 45:1113-1118. discussion 1118-1119.
23. Lankiewicz M.W., Hays J., Friedman K.D., et al. Urgent reversal of warfarin with prothrombin complex concentrate. Thromb Haemost 2006, 4:967-970.
24. Vigué B., Ract C., Tremey B., et al. Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage. Intensive Care Med 2007, 33:721-725.
25. Bertram M., Bonsanto M., Hacke W., Schwab S. Managing the therapeutic dilemma: Patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J Neurol 2000, 247:209-214.
26. Wilcox C.M., Truss C.D. Gastrointestinal bleeding in patients receiving long-term anticoagulant therapy. Am J Med 1988, 84:683-690.
27. Rubin T.A., Murdoch M., Nelson D.B. Acute GI bleeding in the setting of supratherapeutic international normalized ratio in patients taking warfarin: Endoscopic diagnosis, clinical management, and outcomes. Gastrointest Endosc 2003, 58:369-373.
28. Mortality statistics: Deaths registered in 2007 Office for National Statistics, Accessed September 18, 2009. http://www.statistics.gov.uk/downloads/theme_health/DR2007/DR_07_2007.pdf.
29. Sandercock P., Berge E., Dennis M., et al. A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. Health Technol Assess 2002, 6:1-112.
30. Leontiadis G.I., Sreedharan A., Dorward S., et al. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess 2007, 11:iii-iv. 1-164.
31. Varney S.J., Guest J.F. The annual cost of blood transfusions in the UK. Transfus Med 2003, 13:205-218.
32. NHS Reference Costs 2009/10: Collection guidance Department of Health, Accessed September 18, 2009. http://www.dh.gov.uk.
33. Reducing brain damage: Faster access to better stroke care November 2005, National Audit Office, Department of Health, National Audit Office, Accessed September 18, 2009. http://www.nao.org.uk/publications/0506/reducing_brain_damage.aspx.
34. Drug Tariff 2009 Accessed September 18, 2009. http://www.drugtariff.com.
35. British National Formulary 2009 Accessed September 18, 2009. http://www.bnf.org.
36. Curtis L. Unit costs of health and social care, 2008 Accessed September 18, 2009. http://kar.kent.ac.uk/15492/1/uc2008.pdf.
37. Evans G., Luddington R., Baglin T. Beriplex P/N reverses severe warfarininduced overanticoagulation immediately and completely in patients presenting with major bleeding. Br J Haematol 2001, 115:998-1001.
38. Makris M., Greaves M., Phillips W.S., et al. Emergency oral anticoagulant reversal: The relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997, 77:477-480.
39. Limaye S., Bamford J., Button T., et al. Urgent warfarin reversal is poorly executed in patients hospitalised with oral anticoagulation therapy related intracerebral haemorrhage (OAT-ICH) Accessed November 29, 2010. http://stroke.ahajournals.org/cgi/reprint/40/4/e105.
40. Watson H., Salamat A., Seaton J. Audit of Use of Prothrombin Complex Concentrate in Warfarin Reversal: Pre and Post Guidelines 2004, Grampian University Hospital Trust, Aberdeen, UK.
41. Guide to the methods of technology appraisal (reference N0515) National Institute for Health and Clinical Excellence, Accessed September 18, 2009. http://www.nice.org.uk/niceMedia/pdf/TAP_Methods.pdf.